Related Internet Sites
- CDC Emergency Preparedness and Response
- CDC National Center for Infectious Diseases
- CDC National Immunization Program
- Department of Defense Anthrax Vaccine Immunization Program
- Use of anthrax vaccine in the United States, Advisory Committee on Immunization Practices. MMWR 2000; 49 RR-15: 1-20, and Notice to Readers: Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR 2002; 45 RR-15: 1024-1026.
- CDC. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR 2001; 50: 909-919.
- Hoffmaster AR, Meyer, RF, Bowen MB, et al. Evaluation and validation of real-time PCR assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002; 8: 1178-1181.
- Hoffmaster A, Fitzgerald V, Ribot E, Mayer LW, Popovic T. Importance of molecular subtyping of Bacillus anthracis during recent-multi-state bioterrorism associated anthrax outbreak in the United States. Emerg Infect Dis 2002; 8: 1111-1116.
- Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8: 1019-1028.
- Quinn CP, Dull PM, Semenova V, Let al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis 2004; 190(7): 1228-36.
- Centers for Disease Control and Prevention. Inhalation anthrax associated with dried animal hides - Penbnsylvania and New York City, 2006. MMWR Morb Mortal Wkly Rep 2006; 55: 280-282.